全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Effectiveness of Botulinum Toxin A First Injection on Gastrocnemius Muscle Spasticity in Children with Cerebral Palsy: Clinical and Elastosonography Study

DOI: 10.4236/oalib.1110517, PP. 1-13

Subject Areas: Clinical Medicine, Pharmacology

Keywords: Cerebral Palsy, Muscle Spasticity, Elastosonography, Botulinum Toxins, Type A

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: An accurate assessment of the spasticity in the spastic forms of cerebral palsy (CP) is important to establish the effectiveness of therapeutic management. The modified Ashworth scale (MAS) is the most frequently used method in the assessment of spasticity in clinical practice. However, this method does not allow an objective, precise and reliable assessment because of the lack of standardization and the low level of reliability. Elastosonography (ES) is an imaging method that assesses the viscoelastic characteristics of tissues non-invasively. Aim: The aim of this study was to assess the stiffness of gastrocnemius muscle (GCM) in children with spastic CP by ES and to investigate the sonoelastographic changes and its correlations with clinical evaluation parameters (MAS) after botulinum toxin type A (BTA) injections. Methods: This prospective, analytical and diagnostic study involved children with spastic CP receiving a first injection of BTA to GCM. Muscle stiffness was measured with MAS and ES before the procedure, and at 1, 2, 3, 4 weeks, 3 and 6 months post-injection. ES parameter [Strain Index Value (SIV)] and MAS scores before and after the treatment were compared. Results: Fifteen children with spastic CP were enrolled in the study. The mean age was 6.8 years ± 3.85 and the mean body weight was 21.4 kg ± 7.8. Abobotulinum toxin A (Dysport®) injections were administered to 5 children (33.3%) with an average dose of 180 ± 179.44 units and Onabotulinum toxin A (Botox®) injections were administered to 10 children (66.7%) with an average dose of 63 ± 27.51 units in GCM. The average MAS score was 2.5 and SIV was measured as 2.38 ± 0.57 before BTA. At 2 weeks after BTA injection, significant improvements were observed in MAS grades and SIV (p < 0.05). These statistically significant improvements persisted for up to 3 months for the MA score and only 2 months for the SIV. Positive significant correlations were observed between the SIV and the MAS score at different times of the evaluation. Conclusion: The results of this study suggest that ES is a promising diagnostic tool allowing the assessment of the viscoelasticity of spastic muscles in real time as it was described in the spasticity stretch reflex.

Cite this paper

Boudokhane, S. , Kalai, A. , Migaou, H. , Borgi, O. , Hmida, B. , Jellad, A. and Frih, Z. B. S. (2023). Effectiveness of Botulinum Toxin A First Injection on Gastrocnemius Muscle Spasticity in Children with Cerebral Palsy: Clinical and Elastosonography Study. Open Access Library Journal, 10, e517. doi: http://dx.doi.org/10.4236/oalib.1110517.

References

[1]  Graham, H.K. and Selber, P. (2003) Musculoskeletal Aspects of Cerebral Palsy. The Bone & Joint Journal, 85, 157-166. https://doi.org/10.1302/0301-620X.85B2.14066
[2]  Graham, H.K., Rosenbaum, P., Paneth, N., Dan, B., Lin, J.-P., Damiano, D.L., et al. (2016) Cerebral Palsy. Nature Reviews Disease Primers, 2, Article No. 15082. https://doi.org/10.1038/nrdp.2015.82
[3]  Johnson, D., Damiano, D. and Abel, M. (1997) The Evolution of Gait in Childhood and Adolescent Cerebral Palsy. Journal of Pediatric Orthopaedics, 17, 392-396. https://doi.org/10.1097/01241398-199705000-00022
[4]  Gough, M., Eve, L.C., Robinson, R.O. and Shortland, A.P. (2004) Short-Term Outcome of Multilevel Surgical Intervention in Spastic Diplegic Cerebral Palsy Compared with the Natural History. Developmental Medicine & Child Neurology, 46, 91-97. https://doi.org/10.1111/j.1469-8749.2004.tb00457.x
[5]  Rodda, J. and Graham, H.K. (2001) Classification of Gait Patterns in Spastic Hemiplegia and Spastic Diplegia: A Basis for a Management Algorithm. European Journal of Neurology, 8, 98-108. https://doi.org/10.1046/j.1468-1331.2001.00042.x
[6]  Sheean, G.L. (2001) Botulinum Treatment of Spasticity: Why Is It So Difficult to Show a Functional Benefit? Current Opinion in Neurology, 14, 771-776. https://doi.org/10.1097/00019052-200112000-00015
[7]  Bohannon, R.W. and Smith, M.B. (1987) Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity. Physical Therapy, 67, 206-207. https://doi.org/10.1093/ptj/67.2.206
[8]  Blackburn, M., van Vliet, P. and Mockett, S.P. (2002) Reliability of Measurements Obtained with the Modified Ashworth Scale in the Lower Extremities of People with Stroke. Physical Therapy, 82, 25-34. https://doi.org/10.1093/ptj/82.1.25
[9]  Brandenburg, J.E., Eby, S.F., Song, P., et al. (2014) Ultrasound Elastography: The New Frontier in Direct Measurement of Muscle Stiffness. Archives of Physical Medicine and Rehabilitation, 95, 2207-2219. https://doi.org/10.1016/j.apmr.2014.07.007
[10]  Ceyhan Bilgici, M., Bekci, T., Ulus, Y., Bilgici, A., Tomak, L. and Selcuk, M.B. (2018) Quantitative Assessment of Muscle Stiffness with Acoustic Radiation Force Impulse Elastography after Botulinum Toxin A Injection in Children with Cerebral Palsy. Journal of Medical Ultrasonics, 45, 137-141. https://doi.org/10.1007/s10396-017-0780-y
[11]  Kwon, D.R., Park, G.Y. and Kwon, J.G. (2012) The Change of Intrinsic Stiffness in Gastrocnemius after Intensive Rehabilitation with Botulinum Toxin A Injection in Spastic Diplegic Cerebral Palsy. Annals of Rehabilitation Medicine, 36, 400-403. https://doi.org/10.5535/arm.2012.36.3.400
[12]  Park, G.-Y. and Kwon, D.R. (2012) Sonoelastographic Evaluation of Medial Gastrocnemius Muscles Intrinsic Stiffness after Rehabilitation Therapy with Botulinum Toxin A Injection in Spastic Cerebral Palsy. Archives of Physical Medicine and Rehabilitation, 93, 2085-2089. https://doi.org/10.1016/j.apmr.2012.06.024
[13]  Boyaci, A., Tutoglu, A., Boyaci, N., Koca, I., Calik, M., Sakalar, A., et al. (2014) Changes in Spastic Muscle Stiffness after Botulinum Toxin A Injections as Part of Rehabilitation Therapy in Patients with Spastic Cerebral Palsy. NeuroRehabilitation, 35, 123-129. https://doi.org/10.3233/NRE-141107
[14]  SCPE Collaborative Group (2002) Prevalence and Characteristics of Children with Cerebral palsy in Europe. Developmental Medicine & Child Neurology, 42, 633-624.
[15]  Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E. and Galuppi, B. (1997) Development and Reliability of a System to Classify Gross Motor Function in Children with Cerebral Palsy. Developmental Medicine & Child Neurology, 39, 214-223. https://doi.org/10.1111/j.1469-8749.1997.tb07414.x
[16]  Novacheck, T.F., Stout, J.L. and Tervo, R. (2000) Reliability and Validity of the Gillette Functional Assessment Questionnaire as an Outcome Measure in Children with Walking Disabilities. Journal of Pediatric Orthopaedics, 20, 75-81. https://doi.org/10.1097/01241398-200001000-00017
[17]  Palisano, R.J., Hanna, S.E., Rosenbaum, P.L., Russell, D.J., Walter, S.D., Wood, E.P., et al. (2000) Validation of a Model of Gross Motor Function for Children with Cerebral Palsy. Physical Therapy, 80, 974-978. https://doi.org/10.1093/ptj/80.10.974
[18]  Rodda, J.M., Graham, H.K., Carson, L., Galea, M.P. and Wolf, R. 2004) Sagittal Gait Patterns in Spastic Diplegia. The Bone & Joint Journal, 6, 251-258. https://doi.org/10.1302/0301-620X.86B2.13878
[19]  Agence nationale de sécurité du médicament et des produits de santé (2011) Résumé des caractéristiques du produit. http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=60242321&typedoc=N&ref=N0390734.htm
[20]  Agence nationale de sécurité du médicament et des produits de santé (2015) Résumé des caractéristiques du produit. http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=62395974&typedoc=N&ref=N0401273.htm
[21]  Van Campenhout, A. and Molenaers, G. (2011) Localization of the Motor Endplate Zone in Human Skeletal Muscles of the Lower Limb: Anatomical Guidelines for Injection with Botulinum Toxin. Developmental Medicine & Child Neurology, 53, 108-119. https://doi.org/10.1111/j.1469-8749.2010.03816.x
[22]  Picelli, A., Dambruoso, F., Bronzato, M., et al. (2014) Efficacy of Therapeutic Ultrasound and Transcutaneous Electrical Nerve Stimulation Compared with Botulinum Toxin Type A in the Treatment of Spastic Equinus in Adults with Chronic Stroke: A Pilot Randomized Controlled Trial. Topics in Stroke Rehabilitation, 21, S8-S16. https://doi.org/10.1310/tsr21S1-S8
[23]  Askin, A., Kalayci, Ö.T., Bayram, K.B., et al. (2017) Strain Sonoelastographic Evaluation of Biceps Muscle Intrinsic Stiffness after Botulinum Toxin-A Injection. Topics in Stroke Rehabilitation, 24, 12-17. https://doi.org/10.1080/10749357.2016.1183865
[24]  Kwon, D.R., Park, G.Y., Lee, S.U. and Chung, I. (2012) Spastic Cerebral Palsy in Children: Dynamic Sonoelastographic Findings of Medial Gastrocnemius. Radiology, 263, 794-801. https://doi.org/10.1148/radiol.12102478
[25]  Lee, W.-Y., Park, G.-Y. and Kwon, D.R. (2014) Comparison of Treatment Effects Between Children with Spastic Cerebral Palsy Under and over Five Years after Botulinum Toxin Type A Injection. Annals of Rehabilitation Medicine, 38, 200-208. https://doi.org/10.5535/arm.2014.38.2.200
[26]  Dashtipour, K., Chen, J.J., Walker, H.W. and Lee, M.Y. (2016) Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity. Medicine, 95, e2468. https://doi.org/10.1097/MD.0000000000002468
[27]  Dashtipour, K., Chen, J.J., Walker, H.W. and Lee, M.Y. (2015) Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity. American Journal of Physical Medicine & Rehabilitation, 94, 229-238. https://doi.org/10.1097/PHM.0000000000000208
[28]  Kesikburun, S., Yasar, E., Adigüzel, E., Güzelküçük, ü., Alaca, R. and Tan, A.K. (2015) Assessment of Spasticity with Sonoelastography Following Stroke: A Feasibility Study. PM&R, 7, 1254-1260. https://doi.org/10.1016/j.pmrj.2015.05.019

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413